XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/06/2026
Back to search
Official data from USPTO
N
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/06/2026
Trademark type
Combined
Nice classes
5
Filing date
02/17/2025
Registration date
01/27/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2026
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
CN
Examiner
GARTNER, JOHN M
Law office
N10
Current location
TMO LAW OFFICE 119
Mark description
The mark consists of the stylized letter "N" where the two outer lines are in blue and the middle line is in orange-red with three horizontal bands across the middle; there is a design of an orange-red sphere overlapping the left side of the letter.
Holders and representatives
Holders
Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Jiangsu Aidea Pharmaceutical Co., Ltd.
Representatives
Prakash NAMA
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Injectable pharmaceutical preparations for the treatment of HIV infection; medicinal preparations for human purposesmedicinal preparations for the treatment of HIV infection; biochemical pharmaceutical preparations for the treatment of HIV infection; biological preparations for medical purposesbiological preparations for the treatment of HIV infection; chemical preparations for medical purposeschemical preparations for the treatment of HIV infection; pharmaceutical preparations for the treatment of HIV infection; chemical preparations for pharmaceutical purposeschemical preparations for the treatment of HIV infection; medicines in the form of tabletsantiretroviral tablets for the treatment of HIV infection.
Publications
History of USPTO decisions and trademark events.
25 publications found
XXCR
GENERIC MADRID TRANSACTION CREATED
08/06/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/27/2026
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/02/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2026
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/09/2025
PUBO
PUBLISHED FOR OPPOSITION
12/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/25/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/22/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/22/2025
RFNT
REFUSAL PROCESSED BY IB
10/03/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/12/2025
RFRR
REFUSAL PROCESSED BY MPU
09/12/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/02/2025
CNRT
NON-FINAL ACTION WRITTEN
08/01/2025
DOCK
ASSIGNED TO EXAMINER
08/01/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/31/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/31/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/24/2025
Continuous trademark protection
Get notified about every new filing that threatens N or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.